Interviews

ECMC Logo
02 Oct 2019

Aoife Regan gives an update from the summer, discussing about the Phase I: Where Science Becomes Medicine conference, changes in the Programme Office, and her thoughts for the future.

ECMC logo
27 Sep 2019

The new Lead of the Birmingham ECMC talks to us about his career to date, the biggest challenges facing clinical research, and the exciting, unpredictable future for immunotherapy.

03 Jun 2019

Gareth Veal discusses his team’s new therapeutic drug monitoring service, aiming to assist in the treatment particularly “hard-to-treat” childhood cancer patients.

12 Dec 2018

Aoife Regan has recently returned from maternity leave back to her position as Head of the ECMC Programme Office. Aoife reflects on what’s changed in the network while she’s been away, what she’s planning to focus on and the challenges to come.

ECMC logo
12 Dec 2018

The new Lead of the Manchester ECMC talks to us about her career to date, balancing NHS service and clinical research commitments, precision medicine ... and the Enigma code.

18 Jul 2018

Congratulations on your recent appointment. Can you tell us a little bit about your background, and why you got into clinical research? 

24 May 2018

Congratulations and welcome! Which aspects of your new role are you most excited about?

As part of my role I will lead on the creation of the Experimental Cancer (EC) Trial finder. This database will allow clinical staff to find the most relevant trial for their patients within the ECMC network, based on specific search criteria, including patient molecular profile.

23 May 2018

Can you tell us a little bit about your work, and why you got into clinical research?

My main driver for getting into clinical research was to serve patients. My current work is focused on the conduct of clinical trials pursuing proof of mechanism and proof of concept, as well as translational cancer research.

How did it feel to be awarded this prestigious honour?

04 Dec 2017
We caught up with the new Chief Clinician of Cancer Research UK (CRUK), Professor Charlie Swanton about the future of clinical research and more. Amongst his many achievements, Professor Swanton has published over 120 papers, with first or senior author publications in the New England Journal of Medicine, Nature, Nature Genetics, Cancer Discovery, Cancer Cell, Science and the Lancet Oncology. His work has led to insight into genomic diversity within cancers (intratumour heterogeneity) and molecular mechanisms driving cancer branched evolution.
 
18 Oct 2017

Congratulations and welcome! Which aspects of your new role are you most excited about?

Pages